NCT01812720View on ClinicalTrials.gov

Carfilzomib and Dexamethasone in Treating Patients With Multiple Myeloma Who Previously Underwent a Stem Cell Transplant

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

August 31, 2013

Primary Completion Date

September 30, 2014

Study Completion Date

October 31, 2014

Conditions
Refractory Multiple MyelomaStage I Multiple MyelomaStage II Multiple MyelomaStage III Multiple Myeloma
Interventions
DRUG

carfilzomib

Given IV

DRUG

dexamethasone

Given PO

OTHER

laboratory biomarker analysis

Correlative studies

Trial Locations (3)

55905

Mayo Clinic, Rochester

63110

Washington University School of Medicine, St Louis

91010

City of Hope, Duarte

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Mayo Clinic

OTHER

NCT01812720 - Carfilzomib and Dexamethasone in Treating Patients With Multiple Myeloma Who Previously Underwent a Stem Cell Transplant | Biotech Hunter | Biotech Hunter